Cited by 49Antifungal resistance and susceptibilityFungal Infections and StudiesInfective Endocarditis Diagnosis and Management

Duration of antifungal treatment and development of delayed complications in patients with candidaemia

Oude Lashof, A. M. L., Donnelly, J. P., Meis, J. F. G. M., van der Meer, J. W. M., Kullberg, B. J.·2003·European Journal of Clinical Microbiology and Infectious Diseases

Abstract

The optimal duration of antifungal treatment of candidaemia is unknown. Prolonged treatment has been advocated to prevent late-onset complications caused by metastatic infectious foci. To evaluate the relationship between duration of antifungal therapy and the development of delayed complications in patients with candidaemia, a retrospective descriptive study was performed in a tertiary care centre. The study included 180 consecutive patients with candidaemia identified by at least one positive blood culture. Development of late-onset complications of candidaemia during long-term follow-up was monitored. Of the patients treated with antifungal agents, 55% completed treatment without apparent complications, 33% died during therapy, 12% developed disseminated disease and one patient continues to receive ongoing treatment. Of the 81 patients who completed treatment as scheduled, 25% received treatment for less than 2 weeks, 31% for 2-4 weeks and 38% for more than 4 weeks; duration of therapy was unknown in 6%. Only three (2%) patients developed delayed complications; in these patients, the duration of antifungal treatment had been 3 weeks, 5 weeks and 22 weeks, respectively. In conclusion, despite theoretical concerns, there seems to be no correlation between the duration of antifungal treatment and the development of late complications in patients with candidaemia. This suggests that treatment of 2 weeks or less may be sufficient, provided the initial response to therapy is favourable.

Integrity signals

Registry

Crossref · 10.1007/s10096-002-0854-6

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two weeks of antifungal treatment seem to be sufficient to prevent late complications from clinically important metastatic foci of infection in the vast majority of cases.

    “Two weeks of antifungal treatment seem to be sufficient to prevent late complications from clinically important metastatic foci of infection in the vast majority of cases [93].”

    From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [93]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Oude Lashof, A. M. L., Donnelly, J. P., Meis, J. F. G. M., van der Meer, J. W. M., & Kullberg, B. J.
Affiliations
  • Radboud University Nijmegen (NL)
  • Canisius-Wilhelmina Ziekenhuis (NL)
Corresponding author
Kullberg, B. J.
Venue
European Journal of Clinical Microbiology and Infectious Diseases
Published
2003-01
Volume
22
Issue
1
Pages
43-48
ISSN
  • 0934-9723 (ISSN-L)
  • 1435-4373
OpenAlex
W2112605123
Cited by
49
References
26
Citations by year
2026: 2 · 2025: 3 · 2023: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 3 · 2012: 1
FWCI
2.91
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
Koninklijke Nederlandse Akademie van Wetenschappen
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
candidemia, antifungal therapy duration, late-onset complications, systemic candidiasis, treatment duration, antifungal therapy, mortality, treatment response
MeSH terms
Adult, Aged, Antifungal Agents, Candidiasis, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Male, Middle Aged, Probability, Retrospective Studies, Severity of Illness Index, Time Factors, Survival Rate, Fungemia, Risk Assessment, Statistics, Nonparametric

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review